Relative bioavailability of two oral formulations of risperidone 2 mg: A single-dose, randomized-sequence, open-label, two-period crossover comparison in healthy Brazilian volunteers
- 30 November 2010
- journal article
- research article
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 32 (12), 2106-2115
- https://doi.org/10.1016/j.clinthera.2010.11.006
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Disponibilidade no setor público e preços no setor privado: um perfil de medicamentos genéricos em diferentes regiões do BrasilCadernos de Saude Publica, 2009
- Plasma Pharmacokinetic Characteristics of Risperidone and Their Relationship to Saliva Concentrations in Children with Psychiatric or Neurodevelopmental DisordersClinical Therapeutics, 2007
- Structural studies of impurities of risperidone by hyphenated techniquesJournal of Pharmaceutical and Biomedical Analysis, 2006
- Risperidone for the Core Symptom Domains of Autism: Results From the Study by the Autism Network of the Research Units on Pediatric PsychopharmacologyAmerican Journal of Psychiatry, 2005
- Determination of risperidone and 9-hydroxyrisperidone in human plasma by liquid chromatography: application to the evaluation of CYP2D6 drug interactionsJournal of Chromatography B, 2003
- Validated method for the determination of risperidone and 9-hydroxyrisperidone in human plasma by liquid chromatography–tandem mass spectrometryJournal of Chromatography B, 2002
- Risperidone in Children with Autism and Serious Behavioral ProblemsNew England Journal of Medicine, 2002
- Determination of risperidone and its major metabolite 9-hydroxyrisperidone in human plasma by reversed-phase liquid chromatography with ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 2000
- Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidonePsychopharmacology, 1999
- Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjectsClinical Pharmacology & Therapeutics, 1993